- ZappRx is selling itself to Allscripts, a publicly-traded health IT company, according to sources familiar.
- Allscripts is looking to diversify its business outside of electronic medical records.
- ZappRx was founded by Zoe Barry, who started the company after her brother was diagnosed with epilepsy.
Medical software company Allscripts has bought ZappRx, a start-up that aimed to modernize how people access prescription medicines, say two people familiar with the deal, the company confirmed on Thursday.
ZappRx raised more than $40 million from investors ranging from GV, Alphabet’s early-stage venture arm, and SR One, the corporate venture firm for pharmaceutical giant GlaxoSmithKline. Two people familiar with the deal declined to disclose the financial terms of the deal, but said the price was less than the amount raised in venture capital.
ZappRx did not immediately return requests for comment.
ZappRx had recently announced a slew of large customers and partners, including pharma company Bayer in 2019, and the research group CureDuchenne, in late 2018.